Trials / Completed
CompletedNCT03332420
The Efficacy of Huaiqihuang Granule in Children With Primary Nephrotic Syndrome
A Real-world Study to Evaluate the Efficacy of Huaiqihuang Granule in Children With Primary Nephrotic Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,507 (actual)
- Sponsor
- Qidong Gaitianli Medicines Co., Ltd · Industry
- Sex
- All
- Age
- 1 Year – 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multisite, open-label, prospective and registered study designed to evaluate the efficacy and safety of Huai-Qi-Huang granule in children with primary nephrotic syndrome.
Detailed description
This is a multisite, open-label, prospective and registered study designed to evaluate the efficacy and safety of Huai-Qi-Huang granule in children with primary nephrotic syndrome(PNS). The study will be Planned at 1500 participants, and subjects will be on study for up to one year. Data will be collected by authorized physicians for 48 weeks. all of the data included demographic characteristics, information about PNS, laboratory tests and adverse events.
Conditions
Timeline
- Start date
- 2017-11-16
- Primary completion
- 2021-07-21
- Completion
- 2021-08-31
- First posted
- 2017-11-06
- Last updated
- 2022-12-22
Locations
17 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03332420. Inclusion in this directory is not an endorsement.